We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determination of Glycemic Index (GI) of Ten Food Products

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01679704
Recruitment Status : Completed
First Posted : September 6, 2012
Last Update Posted : August 4, 2014
Sponsor:
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.

Brief Summary:
This study is initiated to investigate the glycemic index value of ten food products.

Condition or disease Intervention/treatment
Glycemic Index Dietary Supplement: Food products

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Determination of Glycemic Index (GI) of Ten Food Products
Study Start Date : February 2012
Primary Completion Date : April 2012
Study Completion Date : April 2012

Arm Intervention/treatment
Food products
Ten food products will be given to all subjects
Dietary Supplement: Food products



Primary Outcome Measures :
  1. Glycemic index values of all ten products [ Time Frame: 120 minutes post adminstration ]
    Glycemic index values at 120 minutes post adminstration.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy non-pregnant females (at least 6 weeks postpartum, non-lactating)
  • Age between 21 to 60 years

Exclusion Criteria:

  • Suffering from any chronic diseases.
  • Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
  • History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
  • Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
  • Known food allergy or intolerance.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01679704


Locations
Singapore
Temasek Polytechnic
Singapore, Singapore
Sponsors and Collaborators
Danone Asia Pacific Holdings Pte, Ltd.
Investigators
Principal Investigator: Kalpana Bhaskaran, Dr Temasek Polytechnic

Responsible Party: Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier: NCT01679704     History of Changes
Other Study ID Numbers: GIS.2012
First Posted: September 6, 2012    Key Record Dates
Last Update Posted: August 4, 2014
Last Verified: August 2014